PPR-162 - Exhaustive computational analysis of pyrimidine derivatives as GPR119 agonists for the treatment of Type 2 Diabetes Mellitus

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-162
• By: NEMA, Priyanshu (Integrated Drug Discovery Research Laboratory, Department of Pharmaceutical Sciences, Dr Hari Singh Gour University Department Of Pharmaceutical Sciences, India)
• Co-author(s): Mr Priyanshu Nema (Integrated Drug Discovery Research Laboratory, Department of Pharmaceutical Sciences, Dr Hari Singh Gour University Department Of Pharmaceutical Sciences, Sagar, India)
  Prof Sushil Kumar Kashaw (Integrated Drug Discovery Research Laboratory, Department of Pharmaceutical Sciences, Dr Hari Singh Gour University Department Of Pharmaceutical Sciences, Sagar, India)
  
• Abstract:

  Abstract: (1) Background: Type-2 Diabetes (T2DM) is a long-term medical disorder characterized by Insulin deficiency and high blood glucose levels. Among other medication to cure T2DM, the review of the literature found that various Pyrimidine derivative act as an agonist for G-protein-coupled receptor 119 (GPR119) was proposed to control blood..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login